PetMed Express, Inc.
PETS
$4.19
$0.020.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -10.82% | -4.13% | 2.21% | 9.49% | 6.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.82% | -4.13% | 2.21% | 9.49% | 6.40% |
| Cost of Revenue | -10.28% | -3.74% | 2.80% | 8.92% | 6.24% |
| Gross Profit | -12.18% | -5.14% | 0.67% | 10.98% | 6.82% |
| SG&A Expenses | -20.03% | -7.11% | 2.63% | 32.65% | 36.42% |
| Depreciation & Amortization | 11.45% | 32.26% | 58.78% | 98.98% | 90.03% |
| Other Operating Expenses | -416.28% | -416.28% | -185.74% | -185.74% | -62.81% |
| Total Operating Expenses | -12.92% | -4.44% | 2.80% | 14.90% | 13.83% |
| Operating Income | 157.61% | 74.17% | -121.85% | -224.90% | -129.90% |
| Income Before Tax | 181.84% | -619.15% | -105.49% | -188.51% | -116.63% |
| Income Tax Expenses | 380.86% | -49.63% | 73.24% | -47.04% | -89.01% |
| Earnings from Continuing Operations | 113.40% | -13.43% | -353.60% | -254.28% | -123.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 113.40% | -13.43% | -353.60% | -254.28% | -123.96% |
| EBIT | 157.61% | 74.17% | -121.85% | -224.90% | -129.90% |
| EBITDA | 283.99% | 38.46% | 1.75% | -112.71% | -87.25% |
| EPS Basic | 112.40% | -16.51% | -350.99% | -252.70% | -123.74% |
| Normalized Basic EPS | 294.62% | -0.57% | -68.33% | -169.78% | -112.06% |
| EPS Diluted | 104.41% | -16.67% | -401.30% | -260.60% | -125.70% |
| Normalized Diluted EPS | 284.10% | -11.05% | -72.11% | -170.42% | -112.30% |
| Average Basic Shares Outstanding | 0.88% | 0.78% | 0.67% | 0.60% | 0.61% |
| Average Diluted Shares Outstanding | 1.32% | 1.22% | 1.57% | 0.87% | 0.75% |
| Dividend Per Share | -100.00% | -100.00% | -75.00% | -50.00% | -25.00% |
| Payout Ratio | 1.08% | 0.99% | -1.10% | -1.33% | -4.17% |
